Community-Acquired Pneumonia Outpatient Therapy
A 45-year-old man who smokes and has type 2 diabetes mellitus has three days of fever and productive cough. He is fully alert and oriented. Temperature is 38.3 °C, blood pressure 128/76 mm Hg, respiratory rate 20 breaths/min, and oxygen saturation 96% on room air. Blood urea is 5.1 mmol/L and chest radiography shows a right lower lobe infiltrate. Which of the following is the most appropriate management?
- A.Admission for intravenous ceftriaxone and azithromycin
- B.Oral azithromycin monotherapy as an outpatient
- C.Oral amoxicillin-clavulanate plus azithromycin as an outpatientCorrect
- D.Admission for intravenous ampicillin monotherapy
Explanation
The CURB-65 score here is zero, since the patient is not confused, urea is below 7 mmol/L, respiratory rate is below 30 breaths/min, blood pressure is normal, and he is under 65 years, so outpatient oral therapy is appropriate and admission would be over-treatment. However, he is not a healthy host: diabetes mellitus and active smoking are recognised comorbidities that broaden the likely pathogens beyond Streptococcus pneumoniae to include Haemophilus influenzae, Moraxella catarrhalis, and beta-lactamase producing organisms. Current IDSA and ATS guidance therefore recommends that outpatients with comorbidities receive either combination therapy with a beta-lactam such as amoxicillin-clavulanate or a cephalosporin plus a macrolide or doxycycline, or monotherapy with a respiratory fluoroquinolone. Macrolide monotherapy is reserved for previously healthy outpatients and only where local pneumococcal macrolide resistance is under 25%, which is not the case in most of the Gulf region. Intravenous therapy adds cost, cannula related risk, and nosocomial exposure without benefit in a patient who is eating, drinking, and maintaining saturation. Duration is a minimum of five days, with the patient afebrile for 48 hours and clinically stable before stopping. Failure to improve by 48 to 72 hours should prompt reassessment for empyema, resistant organisms, or an obstructing lesion. Routine follow-up radiography is only needed in smokers over 50 years to exclude an underlying malignancy.
Why each option
- A.
- Admission and intravenous therapy are not justified by a CURB-65 score of zero with normal saturation and no organ dysfunction.
- B.
- Macrolide monotherapy is appropriate only for previously healthy outpatients in areas of low pneumococcal resistance, not for a diabetic smoker.
- C.
- Correct. Low CURB-65 permits outpatient care, and the presence of diabetes and smoking mandates beta-lactam plus macrolide coverage rather than a single narrow agent.
- D.
- Ampicillin alone misses atypical pathogens and beta-lactamase producers, and the intravenous route is unnecessary here.
Reference: IDSA/ATS Community-Acquired Pneumonia in Adults Guideline, 2019
This is one of 3,306 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank